Global Circulating Tumor Cells (CTC) Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue
• 1.4 Market by Type
  • 1.4.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Ex-Vivo Positive Selection
  • 1.4.3 In-Vivo Positive Selection
  • 1.4.4 Negative Selection
  • 1.4.5 Microchips & Single Spiral Micro Channel
• 1.5 Market by Application
  • 1.5.1 Global Circulating Tumor Cells (CTC) Market Share by Application: 2020 VS 2026
  • 1.5.2 Tumorigenesis Research
  • 1.5.3 Emt Biomarkers Development
  • 1.5.4 Cancer Stem Cell Research
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2015-2026)
• 2.2 Global Circulating Tumor Cells (CTC) Growth Trends by Regions
  • 2.2.1 Circulating Tumor Cells (CTC) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Circulating Tumor Cells (CTC) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Circulating Tumor Cells (CTC) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Circulating Tumor Cells (CTC) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Circulating Tumor Cells (CTC) Players by Market Size
  • 3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2015-2020)
  • 3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
  • 3.2.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2019
• 3.3 Circulating Tumor Cells (CTC) Key Players Head office and Area Served
• 3.4 Key Players Circulating Tumor Cells (CTC) Product Solution and Service
• 3.5 Date of Enter into Circulating Tumor Cells (CTC) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2015-2020)
• 4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
• 5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Circulating Tumor Cells (CTC) Market Size (2015-2020)
• 6.2 Circulating Tumor Cells (CTC) Key Players in North America (2019-2020)
• 6.3 North America Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
• 6.4 North America Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Circulating Tumor Cells (CTC) Market Size (2015-2020)
• 7.2 Circulating Tumor Cells (CTC) Key Players in Europe (2019-2020)
• 7.3 Europe Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
• 7.4 Europe Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)

8 China

• 8.1 China Circulating Tumor Cells (CTC) Market Size (2015-2020)
• 8.2 Circulating Tumor Cells (CTC) Key Players in China (2019-2020)
• 8.3 China Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
• 8.4 China Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Circulating Tumor Cells (CTC) Market Size (2015-2020)
• 9.2 Circulating Tumor Cells (CTC) Key Players in Japan (2019-2020)
• 9.3 Japan Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
• 9.4 Japan Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Circulating Tumor Cells (CTC) Market Size (2015-2020)
• 10.2 Circulating Tumor Cells (CTC) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)

11 India

• 11.1 India Circulating Tumor Cells (CTC) Market Size (2015-2020)
• 11.2 Circulating Tumor Cells (CTC) Key Players in India (2019-2020)
• 11.3 India Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
• 11.4 India Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Circulating Tumor Cells (CTC) Market Size (2015-2020)
• 12.2 Circulating Tumor Cells (CTC) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
• 12.4 Central & South America Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 AdnaGen
  • 13.1.1 AdnaGen Company Details
  • 13.1.2 AdnaGen Business Overview
  • 13.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
  • 13.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2015-2020))
  • 13.1.5 AdnaGen Recent Development
• 13.2 Apocell
  • 13.2.1 Apocell Company Details
  • 13.2.2 Apocell Business Overview
  • 13.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
  • 13.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.2.5 Apocell Recent Development
• 13.3 Biocep
  • 13.3.1 Biocep Company Details
  • 13.3.2 Biocep Business Overview
  • 13.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
  • 13.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.3.5 Biocep Recent Development
• 13.4 Canopus Bioscience
  • 13.4.1 Canopus Bioscience Company Details
  • 13.4.2 Canopus Bioscience Business Overview
  • 13.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
  • 13.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.4.5 Canopus Bioscience Recent Development
• 13.5 Creatv Microtech
  • 13.5.1 Creatv Microtech Company Details
  • 13.5.2 Creatv Microtech Business Overview
  • 13.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
  • 13.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.5.5 Creatv Microtech Recent Development
• 13.6 Ikonisys
  • 13.6.1 Ikonisys Company Details
  • 13.6.2 Ikonisys Business Overview
  • 13.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
  • 13.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.6.5 Ikonisys Recent Development
• 13.7 IV Diagnostics
  • 13.7.1 IV Diagnostics Company Details
  • 13.7.2 IV Diagnostics Business Overview
  • 13.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
  • 13.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.7.5 IV Diagnostics Recent Development
• 13.8 Miltenyi Biotech
  • 13.8.1 Miltenyi Biotech Company Details
  • 13.8.2 Miltenyi Biotech Business Overview
  • 13.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
  • 13.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.8.5 Miltenyi Biotech Recent Development
• 13.9 Nanostring Technologies
  • 13.9.1 Nanostring Technologies Company Details
  • 13.9.2 Nanostring Technologies Business Overview
  • 13.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
  • 13.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.9.5 Nanostring Technologies Recent Development
• 13.10 Rarecells Diagnostics
  • 13.10.1 Rarecells Diagnostics Company Details
  • 13.10.2 Rarecells Diagnostics Business Overview
  • 13.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
  • 13.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 13.10.5 Rarecells Diagnostics Recent Development
• 13.11 Vitatex
  • 10.11.1 Vitatex Company Details
  • 10.11.2 Vitatex Business Overview
  • 10.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
  • 10.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
  • 10.11.5 Vitatex Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer